1. Home
  2. NIC vs SUPN Comparison

NIC vs SUPN Comparison

Compare NIC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nicolet Bankshares Inc.

NIC

Nicolet Bankshares Inc.

HOLD

Current Price

$164.78

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$43.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIC
SUPN
Founded
2000
2005
Country
United States
United States
Employees
1621
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.8B
IPO Year
2002
2010

Fundamental Metrics

Financial Performance
Metric
NIC
SUPN
Price
$164.78
$43.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$175.33
$61.60
AVG Volume (30 Days)
117.7K
536.0K
Earning Date
04-21-2026
05-05-2026
Dividend Yield
1.00%
N/A
EPS Growth
21.49
N/A
EPS
3.56
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$43.96
$22.70
Revenue Next Year
$26.91
$19.14
P/E Ratio
$46.53
N/A
Revenue Growth
N/A
N/A
52 Week Low
$114.12
$40.51
52 Week High
$180.00
$59.68

Technical Indicators

Market Signals
Indicator
NIC
SUPN
Relative Strength Index (RSI) 34.19 48.56
Support Level $161.52 $42.54
Resistance Level $172.73 $52.33
Average True Range (ATR) 3.51 1.17
MACD -0.74 0.25
Stochastic Oscillator 0.00 73.21

Price Performance

Historical Comparison
NIC
SUPN

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: